skip to Main Content

ISPE Announces 2021-2022 Board of Directors Election Results

ISPE announced the results of its 2021–2022 International Board of Directors election, revealing a slate of strategic leaders who represent a variety of pharmaceutical industry sectors. The election is run by an independent third party who provides ISPE with the final audited results.

The Board is responsible for the governance and strategic direction of the Society and will assume their elected positions at the  2021 ISPE Annual Meeting & Expo, taking place from 31 October–3 November in Boston, Massachusetts, USA.

The following pharmaceutical industry leaders have been elected to the 2021–2022 ISPE International Board of Directors:

Officers:

Jörg Zimmermann

Chair

Vice President, Vetter Development Service, External Affairs

Vetter Pharma-Fertigung GmbH & Co.

Michael L. Rutherford

Vice Chair

Executive Director, Computer Systems Quality & Data Integrity

Syneos Health

Scott W. Billman

Treasurer

Global Head of Engineering

Jeffrey A. Biskup, PE

Secretary

CEO and Chairman of the Board

CRB

Joanne R. Barrick, RPh

Past Chair

Advisor, Global Validation

Eli Lilly and Company

Re-elected Directors

Ylva Ek

Chief Quality Officer (CQO)

KeyPlants AB

Lou W. Kennedy

CEO and Owner

Nephron Pharmaceuticals

New Directors

Georg Singewald, PhD

VP, Head of Global Quality Control

Genentech, A Member of the Roche Group

Timothy J.N. Watson, PhD

Executive Director & Team Leader, CMC Advisory Office

Pfizer Inc

Board Members Continuing a Term in 2021-2022


In addition to those named above, the following Directors were elected in 2020 to serve a two-year term and will continue their service on the Board:

Vivianne J. Arencibia

Independent Consultant

Arencibia Quality Compliance Associates

Nina S. Cauchon, PhD

Director Regulatory Affairs – CMC

Amgen Inc.

Chris Chen, PhD

CEO

WuXi Biologics (Shanghai) Co., Ltd.

David Doleski

Compliance Head for Biologics Quality Operations

Sanofi

Teresa Minero

Founder & CEO

LifeBee – Digitalizing Life Sciences

Hirofumi Suzuki, PhD

Product Supply Japan, Head of Product Supply Coordination

Bayer Yakuhin Ltd

Back To Top